Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts
Health Catalyst: A Strong Buy on Robust Growth and Solid Earnings Outlook
Health Catalyst Exec Sells Over $11k in Company Stock
J.P. Morgan Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $13
CCORF Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $11
Buy Rating Affirmed on Health Catalyst Amid Positive Growth and Strategic Initiatives
Health Catalyst to Participate in Upcoming Investor Conferences
Express News | Wishin Expands Relationship With Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite
WISHIN Expands Relationship With Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe Suite
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
Health Catalyst Is Maintained at Overweight by Piper Sandler
Piper Sandler Maintains Health Catalyst(HCAT.US) With Buy Rating, Cuts Target Price to $11
Express News | Health Catalyst Inc : Piper Sandler Cuts Target Price to $11 From $14
One Health Catalyst Insider Raised Their Stake In The Previous Year
Express News | Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target
Barclays Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $14
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT)
Health Catalyst (HCAT) Receives a Buy From Barclays
Express News | Health Catalyst Shares Are Trading Lower After Rising on Thursday Following Strong Q2 Earnings
The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts